Tag: U.S. Biosurgery Market

The U.S. biosurgery market—encompassing hemostats, sealants, adhesion barriers, soft-tissue repair adjuncts, bone graft substitutes, and biologically active surgical materials—is entering a decade of steady, innovation-driven